Atria Wealth Solutions’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-8,229
Closed -$230K 1931
2022
Q4
$230K Sell
8,229
-429
-5% -$11K ﹤0.01% 1523
2022
Q3
$203K Sell
8,658
-6,253
-42% -$189K ﹤0.01% 1549
2022
Q2
$503K Sell
14,911
-8,616
-37% -$302K 0.01% 970
2022
Q1
$821K Buy
+23,527
New +$805K 0.01% 813

Other funds holding OGN

Atria Wealth Solutions's OGN Position: Q1 2023 in Review

Atria Wealth Solutions sold out of Organon & Co (OGN) in Q1 2023, closing a stake of 8,229 shares — an estimated $230K sold.

Atria Wealth Solutions first reported a position in OGN in Q1 2022 and held it in 4 quarters. The position peaked at $821K in Q1 2022. 767 funds tracked by Wall St. Rank hold OGN as of Q1 2023.

  • Atria Wealth Solutions reported no remaining Organon & Co position as of Q1 2023 after selling out during the quarter.
  • Atria Wealth Solutions sold 8,229 Organon & Co shares in Q1 2023, an estimated $230K.
  • Atria Wealth Solutions first reported a position in Organon & Co in Q1 2022 and held it in 4 quarters.
  • Atria Wealth Solutions's Organon & Co position peaked at $821K in Q1 2022.
  • 767 funds tracked by Wall St. Rank held Organon & Co as of Q1 2023.

Based on Atria Wealth Solutions's 13F filing for Q1 2023, filed 10 May 2023.